Keratoconus significantly impacts patients' quality of life. Conventional management often leaves unmet visual needs. Wavefront-guided scleral lenses (wfgSL) and Corneal Tissue Addition Keratoplasty (CTAK) represent the 2 newest advancements in keratoconus management. This evidence and case based guide will provide practitioners with the clinical considerations to confidently select appropriate candidates, manage expectations, understand the science and procedure for each, as well as know the expected outcomes. After this course the practitioner should be able to confidently incorporate these innovations into clinical practice, or at least be aware of their existence, as part of the management of the keratoconus patient.
Speakers: John Gelles, OD and Steven Greenstein, MD
Date: Thursday, March 26, 2026
Time: 5:30 PM - 6:30 PM Pacific Time
Location: Virtual
Moderator: Pending
Cost: Free!
COPE ID: 97608-TD
Category: Trt/Mngmnt Ocular Disease
This event is undergoing COPE approval for 1 hour of CE credit.
Thank you to CorneaGen for exhibiting at this event.
Corneal Tissue Addition for Keratoplasty - CTAK offers an advanced solution for contouring keratoconic eyes to significantly improve sight for patients in need. Using CorneaGen’s Custom Tissue Inlays, CTAK provides patient-ready, gamma-irradiated sterile, non‑immunogenic donated corneal tissue inlays that are laser-cut and customized to patients’ specific severity and cone location.